Bifogade filer
PDF
Kurs & Likviditet
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Bioteknik |
AcouSort AB (publ) ("AcouSort" or the "Company") today announces the preliminary outcome of the rights issue of units, consisting of shares and warrants of series TO2, which was announced on 7 November 2023 (the "Rights Issue"). The preliminary outcome is that the Rights Issue has been subscribed to a total of approximately 93.4 percent, of which approximately 70.8 percent were subscribed with unit rights, approximately 22.6 percent were subscribed without unit rights. Through the Rights Issue, AcouSort is expected to receive approximately MSEK 23.2 before issuing costs.
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, UNITED KINGDOM, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, OR ANY OTHER JURISDICTION WHERE SUCH ACTION IS WHOLLY OR PARTIALLY SUBJECT TO LEGAL RESTRICTIONS. SEE ALSO THE "IMPORTANT INFORMATION" SECTION BELOW.
The subscription period in the Rights Issue ended on 30 November 2023, and the preliminary results show that 390,800 units, equivalent to approximately 70.8 percent of the Rights Issue, were subscribed for through the support of unit rights. In addition, 124,726 units were subscribed for without the support of unit rights, equivalent to approximately 22.6 percent of the Rights Issue. Upon full exercise of all issued warrants of series TO2, the Company may additionally receive at most MSEK 10.8 before issuing costs.
Those who have subscribed for units without the support of unit rights will be allocated units according to the principles set out in the information memorandum published by the Company on 14 November 2023. The subscribed and allocated units must be paid in cash according to the instructions on the settlement note. Shareholders registered with a nominee will be notified of their allocation in accordance with the nominee's procedures. Each unit consists of three (3) shares and (1) warrant of series TO 2. The final outcome of the Rights Issue is expected to be announced around 4 December 2023.
Through the Rights Issue, the share capital in the Company increases by SEK 154,657.80, from SEK 1,324,796.40 to SEK 1,479,454.20, and the number of shares increases by 1,546,578 shares, from 13,247,964 shares to 14,794,542 shares, corresponding to a dilution effect of approximately 10.5 percent. Upon full exercise of all issued warrants of series TO2, the share capital will increase by an additional SEK 51,552.60 and the number of shares by an additional 515,526 shares, corresponding to a dilution effect of approximately 3,4 percent.
Advisors
Penser By Carnegie, Carnegie Investment Bank AB (publ) is the financial advisor and issuing agent and Fredersen Advokatbyrå AB is legal advisor to AcouSort in connection with the Rights Issue.
This is information of the type that AcouSort AB (publ) is obligated to make public in accordance with the EU Market Abuse Regulation. The information was submitted for publication through the agency of the contact person above on 2023-11-30 7:00 pm CET.